The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Haploidentical transplantation (HaploSCT) with post-transplant cyclophosphamide (PTCy) and melphalan-based conditioning: A retrospective analysis of the first 100 patients treated at MD Anderson Cancer Center.
Piyanuch Kongtim
No relevant relationships to disclose
Sai Ravi Pingali
No relevant relationships to disclose
Antonio Martin Jimenez
No relevant relationships to disclose
Gabriela Rondon
No relevant relationships to disclose
Julianne Chen
No relevant relationships to disclose
Betul Oran
No relevant relationships to disclose
Partow Kebriaei
No relevant relationships to disclose
Aimee Hammerstrom
No relevant relationships to disclose
Roberto Ferro
No relevant relationships to disclose
Lindsey Lombardi
No relevant relationships to disclose
Martin Korbling
No relevant relationships to disclose
Uday R. Popat
No relevant relationships to disclose
Simrit Parmar
No relevant relationships to disclose
Dean Anthony Lee
No relevant relationships to disclose
Laurence Cooper
Honoraria - Millennium
Katy Rezvani
No relevant relationships to disclose
Elizabeth J. Shpall
No relevant relationships to disclose
Richard E. Champlin
No relevant relationships to disclose
Stefan O. Ciurea
No relevant relationships to disclose